BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis - Summary - MDSpire

BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis

  • By

  • Caroline Gertrud Bergner

  • Franziska van der Meer

  • Jonas Franz

  • Aigli Vakrakou

  • Thea Würfel

  • Stefan Nessler

  • Lisa Schäfer

  • Cora Nau-Gietz

  • Anne Winkler

  • Nielsen Lagumersindez-Denis

  • Claudia Wrzos

  • Ioanna Alkmini Damkou

  • Christina Sergiou

  • Verena Schultz

  • Carolin Knauer

  • Imke Metz

  • Erik Bahn

  • Enrique Garea Rodriguez

  • Doron Merkler

  • Mikael Simons

  • Christine Stadelmann

  • September 25, 2024

  • 0 min

Share

Objective:

To investigate the role of BCAS1+ oligodendrocytes in remyelination processes in the cortex of multiple sclerosis patients and animal models, highlighting their potential as therapeutic targets.

Key Findings:
  • BCAS1+ oligodendrocytes shift from a quiescent to an activated state during remyelination, co-expressing myelin-associated glycoprotein (MAG), which is crucial for effective myelin regeneration.
  • Activated BCAS1+ oligodendrocytes correlate with myeloid cell density, indicating their role in the immediate regenerative response and potential therapeutic implications.
  • In chronic MS, there is a limited replenishment of BCAS1+ oligodendrocytes, contributing to remyelination failure and highlighting the need for strategies to enhance their replenishment.
Interpretation:

BCAS1+ oligodendrocytes in the adult cortex are pre-differentiated cells that respond rapidly to demyelination, facilitating immediate myelin regeneration and presenting potential targets for therapeutic intervention.

Limitations:
  • Study relies on archival tissue, which may not fully represent current disease states and could introduce biases.
  • Limited sample size for control and MS tissues may affect generalizability.
Conclusion:

BCAS1+ oligodendrocytes play a crucial role in cortical remyelination in MS, but their limited replenishment in chronic stages may hinder effective repair.

Original Source(s)

BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis

  • by Caroline Gertrud Bergner, Franziska van der Meer, Jonas Franz, Aigli Vakrakou, Thea Würfel, Stefan Nessler, Lisa Schäfer, Cora Nau-Gietz, Anne Winkler, Nielsen Lagumersindez-Denis, Claudia Wrzos, Ioanna Alkmini Damkou, Christina Sergiou, Verena Schultz, Carolin Knauer, Imke Metz, Erik Bahn, Enrique Garea Rodriguez, Doron Merkler, Mikael Simons, Christine Stadelmann

  • September 25, 2024

Related Content

Patient Satisfaction in Relapsing-Remitting Multiple Sclerosis: Benefits of Home-Based Self-Administration of Subcutaneous Ofatumumab Compared to Other High-Efficacy Treatments

Trust and anxiety as primary drivers of digital health acceptance in multiple sclerosis: toward an extended disease-specific technology acceptance model

Real-world comparison of anti-CD20 therapies: efficacy, infections, and immune profiles in a German cohort